Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tenofovir”

742 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 742 results

Large-scale testing (Phase 3)Study completedNCT01386294
What this trial is testing

Safety and Effectiveness of Tenofovir Gel in the Prevention of Human Immunodeficiency Virus (HIV-1) Infection in Women and the Effects of Tenofovir Gel on the Incidence of Herpes Simplex Virus (HSV-2) Infection

Who this might be right for
HIV Prevention
CONRAD 2,059
Not applicableUnknownNCT05996094
What this trial is testing

Antiretroviral Adherence and Drug-level Monitoring

Who this might be right for
HIV InfectionsAIDSAntiretroviral Therapy, Highly Active+2 more
Zamrotul Izzah 100
Early research (Phase 1)Study completedNCT00594373
What this trial is testing

Interventional Study of Mucosal and Antimicrobial Responses to Repeated Vaginal Applications of Tenofovir Gel in HIV Uninfected Women

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 30
Early research (Phase 1)Study completedNCT03270969
What this trial is testing

A Pharmacokinetic Evaluation of Tenofovir/Emtricitabine as HIV Pre-Exposure Prophylaxis in Transgender Women

Who this might be right for
HIV Prevention
University of Nebraska 15
Post-approval studies (Phase 4)Ended earlyNCT01014481
What this trial is testing

Appropriate Timing of HAART in Co-infected HIV/TB Patients

Who this might be right for
HIV InfectionsTuberculosis
Bamrasnaradura Infectious Diseases Institute 156
Large-scale testing (Phase 3)Study completedNCT01968551
What this trial is testing

Phase 3 Open-Label Study to Evaluate Switching From Optimized Stable Antiretroviral Regimens Containing Darunavir to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) Fixed Dose Combination (FDC) Plus Darunavir (DRV) in Treatment Experienced HIV-1 Positive Adults

Who this might be right for
HIV-1HIV InfectionsAcquired Immunodeficiency Syndrome
Gilead Sciences 158
Large-scale testing (Phase 3)Study completedNCT00711009
What this trial is testing

Study Comparing Lopinavir/Ritonavir (LPV/r) + Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) With a Nucleoside Sparing Regimen Consisting of Lopinavir/Ritonavir + Raltegravir (RAL)

Who this might be right for
Human Immunodeficiency Virus Infection
Abbott 206
Large-scale testing (Phase 3)Study completedNCT02605954
What this trial is testing

Safety and Efficacy of Switching From Regimens of ABC/3TC + a 3rd Agent to E/C/F/TAF Fixed-Dose Combination (FDC) in Virologically-Suppressed HIV 1 Infected Adults

Who this might be right for
HIV-1 Infection
Gilead Sciences 275
Large-scale testing (Phase 3)Study completedNCT01369212
What this trial is testing

Combination Therapy of Pegylated Interferon Alfa-2a and Tenofovir Versus Tenofovir Monotherapy in Chronic Hepatitis B

Who this might be right for
Hepatitis B
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 201
Early research (Phase 1)Study completedNCT01525628
What this trial is testing

Drug Drug Interaction Study Between BI 201335 and BI 207127 in Chronic Hepatitis C Infected Patients

Who this might be right for
Hepatitis C, Chronic
Boehringer Ingelheim 72
Testing effectiveness (Phase 2)Study completedNCT00958100
What this trial is testing

Raltegravir Switch for Toxicity or Adverse Events

Who this might be right for
HIV/AIDSAntiretroviral TherapyHIV Infections
Catholic University of the Sacred Heart 40
Large-scale testing (Phase 3)Study completedNCT04685512
What this trial is testing

Effect of Tenofovir/Emtricitabine in Patients Recently Infected With SARS-COV2 (Covid-19) Discharged Home

Who this might be right for
Covid19
University Hospital, Caen 60
Early research (Phase 1)Study completedNCT07558967
What this trial is testing

Bioequivalence Study of Tenofovir Disoproxil Fumarate Tablets in Healthy Chinese Subjects

Who this might be right for
Healthy
Haisco Pharmaceutical Group Co., Ltd. 47
Testing effectiveness (Phase 2)Study completedNCT05993767
What this trial is testing

UNIVERSAL 1: Pharmacokinetic Study of a Novel DTG/FTC/TAF Dose Ratio for Children

Who this might be right for
HIV Infection
PENTA Foundation 53
Post-approval studies (Phase 4)UnknownNCT04070079
What this trial is testing

Tenofovir Alafenamide With Fine Needle Aspiration Biopsy in Chronic Hepatitis B:

Who this might be right for
Hepatitis B, Chronic
University Health Network, Toronto 15
Large-scale testing (Phase 3)Study completedNCT04597424
What this trial is testing

Combined Prevention of Sexually Transmitted Infections (STIs) in Men Who Have Sex With Men and Using Oral Tenofovir Disoproxil Fumarate/ Emtricitabine (TDF/FTC) for HIV Pre-Exposure Prophylaxis (PrEP)

Who this might be right for
Unsafe SexRisk-Taking
ANRS, Emerging Infectious Diseases 556
Post-approval studies (Phase 4)UnknownNCT03798119
What this trial is testing

TAF Switch in F3/4 CHB pt With Partial Response to NUC (ESTAB-AFPVR)

Who this might be right for
Hepatitis BFibrosis and Cirrhosis of Liver
Kaohsiung Medical University Chung-Ho Memorial Hospital 80
Early research (Phase 1)Study completedNCT00726336
What this trial is testing

GSK1349572 Drug Interaction With Tenofovir

Who this might be right for
Healthy Subjects
GlaxoSmithKline 16
Testing effectiveness (Phase 2)Looking for participantsNCT04375800
What this trial is testing

Doravirine (DOR) in Human Immunodeficiency Virus (HIV)-Infected Children Aged 4 Weeks to <12 Years and <45 kg (MK-1439-066)

Who this might be right for
Human Immunodeficiency Virus (HIV) Infection
Merck Sharp & Dohme LLC 84
Testing effectiveness (Phase 2)Ended earlyNCT04493216
What this trial is testing

A Dose-Range Finding Clinical Trial Study in Human Immunodeficiency Virus (HIV-1) Infected Treatment-Naive Adults

Who this might be right for
HIV Infections
ViiV Healthcare 161
Next Page